Synthroid

Critical Warnings & Restrictions In Canada

Basic Synthroid Information

• INN (International Nonproprietary Name): Levothyroxine sodium
• Brand Names Available In Canada (English): Synthroid; Eltroxin
• ATC Code: H03AA01
• Forms & Dosages: Oral tablets commonly in strengths such as 25, 50, 75, 88, 100, 112, 125, 137, 150, 175, 200, 300 mcg; oral liquid formulations available in select markets at 25 mcg/mL and 50 mcg/mL.
• Manufacturers In Canada (English): Not specified
• Registration Status In Canada (English): Not specified
• OTC / Rx Classification: Prescription only (Rx)

Immediate Patient Protections And Required Monitoring

Start with absolute contraindications before dispensing.

Do not start levothyroxine in patients with untreated thyrotoxicosis or untreated adrenal insufficiency.

Do not initiate levothyroxine following a recent or ongoing acute myocardial infarction.

Avoid use in patients with known hypersensitivity to levothyroxine or any tablet excipients.

Remember that levothyroxine products in Canada require a prescription and a valid DIN for lawful sale.

Pharmacists must verify the therapy history and current prescription details before dispensing.

Obtain baseline thyroid testing of TSH with or without free T4 prior to initiation when possible.

Repeat TSH testing every four to six weeks after starting or changing dose until values stabilise.

High-risk patients, including those with cardiac disease, the elderly, severe osteoporosis or diabetes, need lower starting doses and closer monitoring.

Advise storage and transport at 20–25°C, protected from light and moisture to protect potency.

Confirm brand or generic consistency because tablets are often colour-coded by strength and switches can confuse patients.

• Checklist: Confirm diagnosis, DIN and valid prescription.
• Checklist: Obtain baseline ECG if cardiac risk present.
• Checklist: Educate patient about empty-stomach dosing 30–60 minutes before breakfast.
• Checklist: Set a monitoring schedule with TSH testing every 4–6 weeks until stable.

High-Risk Groups (Elderly, Pregnant, Indigenous Health Considerations)

Elderly patients require lower starting doses such as 12.5–25 mcg daily with slow uptitration to avoid arrhythmias and ischaemia.

Pregnancy commonly requires an increased levothyroxine dose and trimester-based monitoring because fetal neurodevelopment depends on adequate maternal thyroid hormone.

Recommend TSH checks each trimester and prompt dose adjustments as needed during pregnancy.

Provincial prenatal care pathways and drug-plan adjustments may apply; patients should check their provincial program for details.

Indigenous health considerations include ensuring culturally safe communication and addressing access barriers in remote communities.

Coordinate with local health centres and Indigenous health programs when follow-up or supply continuity is a concern.

Verify supply chains and storage measures during transport to remote communities to maintain product potency.

Document any dose changes in shared records and communicate adjustments to primary care and community pharmacists.

• Monitoring Schedule: Baseline TSH; 4–6 weekly checks until stable; trimester checks in pregnancy; tighter cardiac monitoring in elderly with heart disease.
• Definition: DIN — Drug Identification Number linking product to Health Canada records.
• Definition: TSH — Thyroid-Stimulating Hormone used to guide therapy adjustments.

Interaction With Activities (Driving, Machinery, Workplace Safety Under Canadian Law)

Most adverse effects from levothyroxine reflect over-replacement such as tachycardia, tremor and insomnia which can transiently impair driving or machinery operation.

Advise patients to avoid safety-sensitive tasks if they notice palpitations, dizziness, confusion or tremor until medically assessed.

If prolonged symptoms affect duties, employers and occupational health services should be informed as some provincial workplace safety laws require fitness-for-duty assessments for safety-critical roles.

Counsel patients that stable replacement therapy usually has minimal cognitive or motor impairment.

Instruct patients to document symptoms, timing relative to dose changes, and to report issues promptly to their prescriber and pharmacist.

• Checklist For New Therapy: Monitor closely during first four to eight weeks for new symptoms.
• Checklist For New Therapy: Avoid driving or operating machinery if symptomatic.
• Checklist For New Therapy: Inform employer if job is safety-critical and symptoms persist.

Q&A — “Can I Drive After Taking It In Canada?”

Q: Can I drive after taking levothyroxine (Synthroid) in Canada?

A: Normally yes since levothyroxine is not sedating, but do not drive if you develop over-replacement symptoms such as palpitations, tremor, dizziness or confusion.

A: Document symptoms and report them to your prescriber and pharmacist and follow provincial occupational safety guidance if your role is safety-sensitive.

Usage Basics For Canadians

INN, Brand Names Available In Canada

The International Nonproprietary Name is levothyroxine sodium, the active ingredient in Synthroid and Eltroxin.

In Canada, Synthroid and Eltroxin are marketed as tablet formulations in multiple strengths to allow accurate titration by weight and TSH response.

Tablets are commonly colour-coded by strength which helps reduce dispensing errors when patients remain on the same product.

Clinicians and pharmacists should record the brand and DIN on prescriptions and medication records to support consistent dispensing of the same product.

Legal Classification Under Health Canada (Prescription Vs OTC)

Levothyroxine is classified as prescription-only (Rx) and requires a valid prescription and DIN for lawful sale in Canada.

Provincial dispensing regulations and substitution policies vary and some provinces require patient consent before switching brands or generics.

• Keep medication in original packaging and note the DIN and brand on refill requests.
• Bring prior medication bottles to the pharmacy when asking for a refill to avoid unintended substitution.
• Present prior prescriptions and recent TSH results if possible when transferring pharmacies.

Canadian Dosing Guide

Standard Regimens (Health Canada Approved)

Initial adult dosing typically begins at 25–50 mcg once daily and is titrated every four to six weeks based on TSH results.

Full replacement usually averages about 1.6 mcg per kg per day once daily, adjusted to patient weight and clinical response.

Children and neonates follow weight-based dosing, with neonates requiring substantially higher mcg/kg doses such as 10–15 mcg/kg/day in severe congenital hypothyroidism.

Elderly patients should start at lower doses such as 12.5–25 mcg/day with cautious uptitration due to cardiovascular sensitivity.

For thyroid cancer or post-thyroidectomy suppression therapy, doses are individualized and often higher to achieve target TSH suppression.

Adjustments For Comorbidities (E.g., Diabetes)

Levothyroxine can influence glycaemic control in people with diabetes, so monitor blood glucose and adjust diabetes therapy as necessary after starting or changing dose.

Patients with cardiovascular disease require slower titration and consideration of cardiology input prior to full replacement dosing.

Liver and kidney impairment generally require close monitoring rather than fixed dose changes, because metabolism and elimination may be altered.

• Titration Steps: Start low in high-risk patients, recheck TSH in 4–6 weeks, increase by 12.5–25 mcg increments as guided by results.
• Adult Healthy Starting Dose: 25–50 mcg/day then titrate.
• Elderly Or Cardiac Disease Starting Dose: 12.5–25 mcg/day with ECG as indicated.
• Pregnancy: Increase dose and check TSH each trimester.

Q&A — “What If I Miss A Dose Under My Provincial Drug Plan?”

Q: What should I do if I miss a dose and have limited access due to provincial plan coverage or refill delays?

A: Take the missed levothyroxine as soon as you remember unless it is close to the next scheduled dose; do not double dose.

A: Contact your pharmacy and provincial drug plan such as ODB, BC PharmaCare or RAMQ for emergency refill or pharmacist-authorized emergency supply policies if you face delays.

A: If supply access is delayed, consult your prescriber for bridging options or a temporary prescription to prevent interruption.

Interaction Chart (Canadian Context)

Food And Drinks (Coffee, Alcohol In Canadian Lifestyle)

Levothyroxine is best taken on an empty stomach 30–60 minutes before breakfast to optimise absorption.

Coffee, high-fibre meals, soy, and calcium- or iron-containing foods or supplements can reduce levothyroxine absorption when taken too close to dosing.

Alcohol does not directly interact with levothyroxine absorption, but chronic alcohol misuse can alter liver function and thyroid balance indirectly.

Common Drug Conflicts (Refer To Health Canada Advisories)

Flag interactions with calcium, iron, aluminium-containing antacids, sucralfate and bile acid sequestrants which reduce oral absorption.

Certain medications such as oestrogens, amiodarone, rifampin, carbamazepine and some proton pump inhibitors can alter levothyroxine metabolism or thyroid hormone requirements.

Recommend separating administration times by two to four hours when feasible, and adjusting dose with laboratory monitoring when interacting drugs are started or stopped.

• Common Interacting Medications: Calcium, iron, aluminium antacids, sucralfate, bile acid sequestrants.
• Metabolism Alterers: Rifampin, carbamazepine, amiodarone, oestrogens.
• Checklist For Reconciliation: Review all OTC supplements, new prescriptions and recent hospital discharge meds at each visit.

User Reports & Trends In Canada

Canadian Patient Forums And Review Platforms

Patients on Canadian forums commonly stress the importance of brand consistency and express frustration with involuntary generic interchange.

Anecdotal interest in liquid formulations appears among patients with malabsorption or swallowing issues seeking steadier control.

Common complaints include mood changes, weight fluctuations and palpitations which often reflect under- or over-replacement rather than the product itself.

Supply continuity is a frequent concern for people living in rural and remote communities where pharmacy stockouts create anxiety about maintaining steady dosing.

Community Pharmacy Feedback

Pharmacists report standard counselling points include timing with food, interactions with calcium and iron supplements, and the value of staying on the same brand when possible because tablets can be colour-coded by strength.

Large pharmacy chains such as Shoppers Drug Mart, Rexall, London Drugs and Jean Coutu offer private counselling, adherence packaging and auto-refill services that help patients stay adherent.

• Common Patient Concerns: Brand switching, refill delays, pregnancy dosing changes, and dosing confusion with multiple pill colours.
• Pharmacist Counselling Checklist: Confirm indication and DIN, explain empty-stomach dosing, review interactions and establish monitoring timeline.

Access & Purchase Options

National Pharmacy Chains

Major Canadian chains including Shoppers Drug Mart, Rexall, London Drugs and Jean Coutu routinely stock levothyroxine brands and generics and provide services like prescription transfer and auto-refill.

Presenting the current prescription with DIN and recorded brand helps avoid unintended substitution at the time of dispensing.

• In-Store Services: Dispensing, private counselling, adherence packaging and prescription transfers.
• Tip: Ask pharmacy to note brand and DIN on record if you prefer consistent product supply.

Online Pharmacies In Canada & Provincial Restrictions

Licensed Canadian online pharmacies may dispense levothyroxine with a valid prescription and should be listed on provincial regulatory sites or the Canadian Pharmacists Association directories.

Some provinces allow pharmacist-authorised renewals or emergency supplies, and patients should check local policies such as those in Ontario or British Columbia.

For remote delivery, verify packaging protects products from extreme heat or moisture during transit and expect original packaging with DIN and expiry on arrival.

In our online pharmacy, synthroid is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

• Verify online pharmacy licensing and look for provincial college registration.
• Expect original packaging, DIN on label and expiry date with any delivery.

Mechanism & Pharmacology

Simplified Explanation (Patient-Friendly)

Levothyroxine sodium is a synthetic form of thyroxine (T4) used to replace deficient thyroid hormone and restore normal metabolism and energy levels.

The body converts T4 to the active hormone T3 in peripheral tissues to exert metabolic and developmental effects.

Symptomatic improvement can take several weeks, and laboratory markers such as TSH guide dose titration.

Clinical Terms (Health Canada Approved Monograph References)

ATC code H03AA01 classifies levothyroxine among systemic hormonal thyroid preparations as synthetic T4.

Pharmacokinetics note variable oral absorption influenced by food and co-medications and an approximate half-life of seven days in euthyroid adults.

• T4 Vs T3: T4 is a prohormone converted to T3 which has direct cellular effects.
• ATC Code: H03AA01 used for classification and formulary listing.
• DIN: Links the product to Health Canada product records and labelling information.

Indications & Off-Label Uses In Canada

Approved Indications (DIN)

Health Canada–approved indications include replacement therapy for hypothyroidism and adjunctive use for TSH suppression after thyroidectomy or in selected thyroid cancer management protocols.

Pharmacists must record the DIN for each dispensed product for accurate records and pharmacovigilance.

Common Off-Label Practices (Canadian Physicians)

Off-label use may be considered for TSH suppression in some nodular goitre cases or select oncologic protocols but requires careful risk–benefit assessment.

Levothyroxine is not approved for weight loss or obesity treatment and using it for these purposes is contraindicated and unsafe.

• Approved Uses: Primary hypothyroidism, TSH suppression when clinically indicated, replacement after thyroidectomy.
• Off-Label Uses: Select suppression strategies for nodular disease or protocols in oncology with specialist oversight.

• Suppression Therapy Pros: May reduce goitre growth or recurrence in specific contexts.
• Suppression Therapy Cons: Increased cardiac risk and bone density loss with prolonged suppression.

Key Clinical Findings

Canadian And International Studies 2022–2025

Recent literature continues to emphasise the clinical importance of consistent product use, as switching brands or generics can affect TSH stability for some patients.

Research interest remains on liquid levothyroxine formulations for patients with gastrointestinal malabsorption or swallowing difficulties where absorption variability is a concern.

Canada-specific randomised controlled trial data are limited, but provincial audit and pharmacovigilance signals highlight adherence challenges, particularly in older adults and remote communities.

Ongoing Health Canada Safety Monitoring

Health Canada actively monitors adverse-event reports and issues safety advisories when needed.

Report suspected adverse reactions such as chest pain, new arrhythmias or severe tremor to MedEffect Canada via the official reporting channels.

• Key Monitoring Metrics: TSH, heart rate and rhythm, symptom review, and bone density when long-term suppression is used.
• Recent Focus Areas: Product consistency, supply continuity and dosing in special populations.

Alternatives Matrix

Comparable Medicines With DIN In Canada

Alternatives are primarily other levothyroxine brands and Health Canada–approved generics with their own DINs.

Combination T4/T3 products exist but are not standard first-line therapy and are considered in selected, refractory cases only.

Pros And Cons Checklist

• Efficacy Equivalence: Generic levothyroxine is therapeutically equivalent when used consistently, but monitor TSH after switches.
• Patient Tolerance: Consider switching if side effects suggest intolerance, with close follow-up.
• Absorption Issues: Consider liquid formulations for malabsorption or adherence problems.
• Cost And Coverage: Consider provincial coverage and patient co-pay when selecting brand vs generic.

• When To Switch Or Retain Brand: Switch only with documented reason, inform patient and recheck TSH after change.

Common Questions From Canadian Patients

Why must I take levothyroxine on an empty stomach?

Taking levothyroxine 30–60 minutes before breakfast reduces the chance that food or coffee will lower absorption.

Can levothyroxine cause weight loss?

Levothyroxine is not approved for weight loss and inappropriate use for that purpose is dangerous.

How often do labs need checking?

Check TSH four to six weeks after starting or changing dose, then at clinician-determined intervals once stable.

What happens during pregnancy?

Pregnant patients usually need dose increases and TSH monitoring each trimester to support fetal neurodevelopment.

• Top Questions: Empty-stomach timing; pregnancy dosing; missed-dose instructions; potential interactions; brand switching; emergency refill procedures; how DIN helps; where to report side effects.
• Short Answer Examples: Missed dose—take when remembered unless near next dose; never double dose.
• Printable Handout Suggestion: One-page checklist with dosing time, interactions to avoid, emergency contacts and DIN recorded.

Coverage & Purchase Comparison Table

Comparison Table — Province/Plan, Coverage Status, Typical Patient Cost, Prescription Required

Step-By-Step Purchase Checklist For Canadian Patients

• Obtain a valid prescription that includes brand and DIN when possible.
• Check your provincial plan or private insurer for coverage and co-pay information.
• Decide between in-store collection or licensed online pharmacy delivery and verify licensing.
• Request same-brand dispensing when stability is important and note DIN on refill requests.
• Arrange auto-refill or continuity supply if living in a remote area to prevent interruptions.

Registration & Regulation

Health Canada Approval

Levothyroxine products such as Synthroid and Eltroxin must hold Market Authorisation with a DIN to be sold in Canada.

Health Canada maintains product monographs and safety advisories that guide clinicians and pharmacists on approved indications and labelling.

DIN Number And Labelling Requirements

The DIN uniquely identifies a marketed product in Canada and links to the official product information file.

Labelling must include active ingredient, strength, lot number and expiry and should be retained in original packaging for accuracy and adverse event reporting.

• Definition: DIN — Drug Identification Number used to track marketed products.
• Definition: Product Monograph — Detailed product information used by health professionals.
• Patient Tip: Record the DIN and batch number when receiving medication to aid in reporting adverse events.

Storage & Handling

Standard Canadian Household Conditions

Store levothyroxine at controlled room temperature between 20–25°C and protect from light and moisture to preserve potency.

Avoid storing tablets in bathrooms, near sinks or in vehicle glove compartments where heat and humidity vary widely.

Keep medication in original packaging which often includes tablet colour coding and expiry information.

For northern and remote deliveries, consider insulated packaging and tracking to avoid exposure to extreme temperatures in transit.

Cold-Chain Requirements (Where Applicable)

Liquid formulations may have additional storage instructions that vary by product; check the product monograph for details.

Document storage conditions during transport to remote communities and advise patients on written storage instructions upon receipt.

• Home Storage Do’s: Keep in original container, store at room temperature, avoid humidity and direct sunlight.
• Home Storage Don’ts: Do not store in the bathroom or in a car during summer or winter.
• Traveller Checklist: Keep medication in carry-on, retain original packaging and carry a copy of prescription and DIN.

Guidelines For Proper Use

Canadian Pharmacist Guidance

Pharmacists should confirm the indication, verify DIN and brand, and counsel patients on taking levothyroxine on an empty stomach 30–60 minutes before breakfast.

Review potential interactions with calcium, iron and other OTC supplements and emphasise missed-dose rules: take as soon as remembered unless near the next scheduled dose and never double dose.

Explain overdose signs like chest pain, rapid heartbeat, tremors and confusion and advise immediate medical attention if these occur.

• Counselling Checklist: Confirm diagnosis and indication, record DIN and brand, explain dosing time, review interacting medications and schedule lab monitoring.
• Suggested Patient Leaflet Elements: Dosing schedule, foods and drugs to avoid near dosing, missed-dose instructions, emergency contact information and DIN recorded.

Provincial Health Authority Recommendations

Follow provincial formularies and clinical pathways for initiation and monitoring and use TSH-guided titration every four to six weeks until stable.

Encourage interdisciplinary care for pregnant patients and elderly patients with cardiac disease and coordinate with Indigenous health programs where culturally safe services are needed.

Prescriber Action Item: Verify diagnosis, start appropriate dose per age and comorbidity, schedule labs, counsel on interactions and storage, and log DIN on the prescription.

Delivery Across Canada (English)